Baerum Sykehus

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation2 trials
• Stroke2 trials
• Crohn's disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 22 trials
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Bayer AG1 trial
• Population Health Research Institute1 trial

Running trials

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

  NCT03968393· Phase 4· Population Health Research Institute· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· Phase 3· Bayer AG· Source